IRONWOOD PHARMACEUTICALS INC Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Ironwood Pharmaceuticals Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Ironwood Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $8.33M, a 5.35% increase year-over-year.
  • Ironwood Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $34M, a 41.5% decline year-over-year.
  • Ironwood Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2023 was $59.6M, a 120% increase from 2022.
  • Ironwood Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2022 was $27M, a 21.4% increase from 2021.
  • Ironwood Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2021 was $22.3M, a 28.5% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $59.6M +$32.5M +120% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-16
2022 $27M +$4.77M +21.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-16
2021 $22.3M -$8.89M -28.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-16
2020 $31.2M -$103K -0.33% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 $31.3M -$9.8M -23.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 $41.1M +$10.2M +32.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-17
2017 $30.9M +$1.69M +5.77% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-13
2016 $29.2M +$3.75M +14.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-25
2015 $25.5M -$715K -2.73% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-22
2014 $26.2M +$6.36M +32% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-22
2013 $19.8M +$2.26M +12.8% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-19
2012 $17.6M +$5.84M +49.8% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-18
2011 $11.7M +$4.24M +56.5% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-07
2010 $7.5M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.